Rhino-Orbital-Cerebral Mucormycosis Treatment

Sinonasal Mucormycosis Amidst the Second Wave of COVID-19 Pandemic; Clinical Spectrum and Outcome in a Tertiary Care Center in Nepal
Delay in the Diagnosis of Osteoarticular Mucormycosis in Diabetic Ketoacidosis: A Learning Opportunity
Utility of Fluorescent Microscopy for Rapid Intraoperative Diagnosis of Rhinocerebral Mucormycosis: Experience from a Tertiary Care Center in Central India
Neurovascular Pathology in Intracranial Mucormycosis: Treatment by Cranial Bypass and Literature Review
Trichosporon asahii and Candida guilliermondii as a Source of Orbital Infection in an Immunocompromised Individual
Comparative Evaluation of Effectiveness of Standard of Care Alone and in Combination With Homoeopathic Treatment in COVID-19-Related Rhino-Orbito-Cerebral Mucormycosis (ROCM): Protocol for a Single Blind, Randomized Controlled Trial
Estimation of the pattern of ocular manifestations, risk factors, and imaging of rhino-orbital-cerebral mucormycosis in COVID-19 patients
Proposed computed tomography severity index for the evaluation of invasive fungal sinusitis: Preliminary results

1. Surgical Intervention

Debridement: Aggressive removal of necrotic tissue.
Orbital Exenteration: Required in severe cases to prevent intracranial spread.

2. Antifungal Therapy

Liposomal Amphotericin B: First-line therapy (5–10 mg/kg/day).
Step-Down Therapy: Posaconazole or Isavuconazole for long-term management.

3. Managing Underlying Conditions

Tight control of blood glucose levels.
Reduce or discontinue corticosteroids.

4. Supportive Care

Oxygen therapy for hypoxia.
Fluid and electrolyte management.